Cidara Therapeutics(us:CDTX)
23.22
+3.15%
Updated on 2024-12-22
Open:22.12
Close:23.22
High:24.00
Low:21.20
Pre Close:22.51
Volume:148362.00
Amount:3.35M
Turnover:1.59%
Shares:9.36M
MarketCap:217.24M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 56 | 1416461 | 31.00% | 6 | 8 | 39 |
| 2024-03-31 | 58 | 1102823 | 1.21% | 7 | 8 | 21 |
| 2023-12-31 | 58 | 1425574 | 1.57% | 5 | 13 | 19 |
| 2023-09-30 | 60 | 24075103 | 26.63% | 7 | 13 | 19 |
| 2023-06-30 | 60 | 26255381 | 29.09% | 6 | 18 | 19 |
| 2023-03-31 | 62 | 27109070 | 30.11% | 21 | 14 | 15 |
| 2022-12-31 | 50 | 26804906 | 36.99% | 8 | 8 | 17 |
| 2022-09-30 | 51 | 27073249 | 38.03% | 5 | 11 | 20 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Bvf Inc/Il | 343056 | 0.38% | 0 | |
| 2024-03-31 | Vanguard Group Inc | 167313 | 0.18% | 0 | |
| 2024-03-31 | Renaissance Technologies Llc | 127749 | 0.14% | 37640 | 41.77% |
| 2024-03-31 | Alethea Capital Management, Llc | 79925 | 0.09% | -1459 | -1.79% |
| 2024-03-31 | Point72 Asset Management, L.P. | 62500 | 0.07% | 0 | |
| 2024-03-31 | 5Am Venture Management, Llc | 56726 | 0.06% | 0 | |
| 2024-03-31 | Geode Capital Management, Llc | 41914 | 0.05% | 1620 | 4.02% |
| 2024-03-31 | Blackrock Inc. | 35771 | 0.04% | -11137 | -23.74% |
| 2024-03-31 | Schonfeld Strategic Advisors Llc | 27600 | 0.03% | -4145 | -13.06% |
| 2024-03-31 | Gsa Capital Partners Llp | 22830 | 0.03% | -4192 | -15.51% |
About
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
Address:6310 Nancy Ridge Drive,Suite 101
Website:http://www.cidara.com
Market Movers